Discover trends, market shifts, and competitive outlooks for the iron deficiency injectable industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Iron Deficiency Injectable Market Expected to Grow Between 2025 And 2029?

The market size for injectable treatments for iron deficiency has seen substantial growth in the past few years. It is anticipated to expand from $14.06 billion in 2024 to $15.37 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. The significant growth observed in the historical period can be associated with the increase in iron deficiency anemia treatments, bariatric surgery patients, pediatric and adolescent patients, along with a rising number of pregnancies.

The market for injectable treatments for iron deficiency is projected to expand significantly in the coming years, reaching an estimated worth of $23.13 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. This growth during the forecast period is likely due to several factors including an aging population, worldwide health campaigns, government efforts, an increase in treatments for chronic diseases, and quick iron replenishment. Key trends expected to shape this forecast period include developments in iron formulations, the utilization of digital health technologies, progress in injectable iron deficiency treatments, and the incorporation of iron-based medications.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12907&type=smp

What are the Fundamental Drivers and Innovations Shaping the Iron Deficiency Injectable Market?

The rise in the incidence of polycystic ovary syndrome (PCOS) is predicted to boost the expansion of the iron deficiency injectables market. PCOS, a hormonal disorder commonly found in individuals with ovaries, predominantly impacts reproductive-aged women, leading to iron overloading. This overload can cause severe blood loss during menstruation, leading to anemia, which can be treated using injectable iron deficiency drugs. As of June 2023, the World Health Organization, a specialized health agency based in the US, estimates that 8-13% of reproductive-age women globally are affected by PCOS, with 70% going undiagnosed. Consequently, the presence of PCOS directly contributes to the growth of the iron deficiency injectables market.

Iron Deficiency Injectable Market Driver: Increase in Malnutrition Prevalence Boosts Iron Deficiency Injectable Market Growth

How Is the Iron Deficiency Injectable Market Segmented?

The iron deficiency injectable market covered in this report is segmented –

1) By Type: Iron Dextran, Iron Sucrose, Ferric Carboxymaltose

2) By Branded or Generics: Branded, Generics

3) By Application: Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, Other Applications

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Iron Dextran: Low Molecular Weight Iron Dextran, High Molecular Weight Iron Dextran

2) By Iron Sucrose: Venofer

3) By Ferric Carboxymaltose: Injectafer, Ferinject

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12907&type=smp

Which Regions Are Driving the Next Phase of the Iron Deficiency Injectable Market Growth?

North America was the largest region in the iron deficiency injectable market in 2024. The regions covered in iron deficiency injectable market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Key Trends Are Shaping the Future of the Iron Deficiency Injectable Market?

Leading firms in the iron deficiency injectables market, such as Daiichi Sankyo Company and American Regent Inc., are pioneering new treatments like INJECTAFER to maintain their market standing. In June 2023, these two American companies introduced INJECTAFER (ferric carboxymaltose injection) for iron deficiency, with the blessing of the US government agency, the Food And Drug Administration. This introduction represents the premier and sole intravenous iron replacement therapy for adult patients with chronic and progressive heart failure that has received FDA sanctioning. INJECTAFER trailed in over 40 clinical trials spread over numerous nations, totaling more than 8,800 test subjects. This recent approval highlights INJECTAFER’s proven and successful application within the patient pool, inclusive of both adult and pediatric patients suffering from iron-deficient anemia and heart failure.

View the full report here:

https://www.thebusinessresearchcompany.com/report/iron-deficiency-injectable-global-market-report

How Is the Iron Deficiency Injectable Market Defined and What Are Its Core Parameters?

Iron deficiency refers to a condition where the body lacks adequate iron, leading to decreased production of red blood cells and hemoglobin. Iron deficiency injectables refer to injectable medications or solutions used to treat iron deficiency. These injectable forms of iron allow for direct delivery of the iron into the bloodstream, bypassing the digestive system.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12907

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model